Silence is deafening when new drugs are not approved
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Skies won’t be friendly in Santa Maria anymore
Santa Maria’s relationship with United Airlines was set up for a breakup a year ago when the Chicago-based carrier stopped flying to Los Angeles and shifted its connecting flights to San Francisco. The final blow came Aug. 1 when United announced a suspension of the SFO flights this fall. The Santa Maria-San Francisco service was Read More →
Inogen’s second quarter revenues, profits way up
Inogen revenues increased 24 percent and profits increased 48 percent, the company said when it released second quarter earnings results Aug. 4 Revenues for the Goleta-based maker of direct-to-consumer respiratory products increased 24 percent from $44 million during the second quarter of 2015 to $54.57 million in 2016, beating analyst revenue estimates of $52.44, million Read More →
Teledyne’s second quarter revenues, profits, earnings per share down
Teledyne Technology revenues fell, profits fell and earnings per share fell during the second quarter, the company announced when it released second quarter earnings results Aug. 4. The Thousand Oaks-based industrial conglomerate saw second quarter revenues fall 6.7 percent from $573.6 million in 2015 to $534.9 million in 2016, which missed analyst estimates of $546.7 Read More →
Inphi completes sale of Rambus
Inphi completed the sale of its memory product business to Sunnyvale-based Rambus Aug. 4. The Santa Clara-based Inphi, which designs chips aimed at packing more memory onto Internet servers and increasing bandwidth, employs a large engineering force in Thousand Oaks. The sale will allow it to focus on its communications business. As part of the Read More →